Repository logo
Communities & Collections
All of DSpace
  • English
  • العربية
  • বাংলা
  • Català
  • Čeština
  • Deutsch
  • Ελληνικά
  • Español
  • Suomi
  • Français
  • Gàidhlig
  • हिंदी
  • Magyar
  • Italiano
  • Қазақ
  • Latviešu
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Српски
  • Svenska
  • Türkçe
  • Yкраї́нська
  • Tiếng Việt
Log In
New user? Click here to register. Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Morocho Zambrano, Alicia de los Ángeles"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Item
    Vínculo clínico epidemiológico entre la diabetes mellitus tipo 2 y la COVID-19
    (Universidad de Cuenca, 2022-09-12) Morocho Zambrano, Alicia de los Ángeles; Neira Borja, James Edward
    Introduction: Multiple studies support the association between type 2 diabetes mellitus (DM2) and the severe clinical course of coronavirus disease 2019 (COVID-19). This systematic review was carried out with the aim of determining the clinical-epidemiological link between DM2 and COVID-19. Methods: A systematic review of articles included in the Embase, Web of Science, Cochrane, PubMed, Scielo and Scopus databases (Q1-Q4), published from February 7, 2020 to October 2021, was carried out. To evaluate the study quality, quality assessment tools were used. Results: A total of 32 studies were analyzed, 65.6% were single-center, 87.5% were retrospective studies, in 18.8% studies only patients with COVID-19 and DM2 were included. In 84.3% of the studies, the predominant sex of the patients was male. In 47% of the studies, the age of the patients was greater than or equal to 60 years. In addition, 90.6% of studies reported comorbidities such as hypertension. 87.5% were good quality studies. Conclusions: The following stand out as points of convergence in the current scenario of the syndemic between COVID-19 and DM2: advanced age, deterioration of the immune response, higher levels of inflammatory markers and the association with complications and comorbidities of DM2. DM2 is considered a high risk factor for critical clinical conditions and deaths from COVID-19. Likewise, possible multifaceted pathological mechanistic pathways triggered by hyperglycemia that cause considerable vulnerability to SARS-CoV-2 infection have been detailed.

DSpace software copyright © 2002-2025 LYRASIS

  • Privacy policy
  • End User Agreement
  • Send Feedback